期刊文献+

难治性溃疡性结肠炎的生物靶向治疗 被引量:2

原文传递
导出
摘要 溃疡性结肠炎(UC)是消化内科常见疾病,也是一种难于治愈、极易复发的疾病。之所以“难于治愈”是因为病因不明,之所以“极易复发”,是无法控制其自然病程。直到生物靶向药物发现以前,本病的内科治疗药物主要是5-氨基水杨酸(5-ASA)、糖皮质激素以及各种免疫调节剂。尽管多数患者经过上述药物治疗可以取得满意的疗效,但也有相当部分患者病程起伏跌宕,久治不愈。
作者 李世荣
出处 《中华医学杂志》 CAS CSCD 北大核心 2008年第44期3099-3101,共3页 National Medical Journal of China
  • 相关文献

参考文献23

  • 1Baumgart DC, Sandborn WJ. Inflammatory bowel disease:clinical aspects and established and evolving therapies. Lancet, 2007, 369 : 1641-1657.
  • 2Baumgart DC, Carding SR. Inflammatory bowel disease:case and immunobiology. Lancet, 2007, 369 : 1627-1640.
  • 3Thukral C, Cheifetz A, Peppercorn MA. Anti-tumour necrosis fatter therapy for ulcerative colitis: evidence to date. Drugs, 2006, 66:2059-2065.
  • 4Ishiguro Y. Mucosal prointlammatory cytokine production correlates with endoscopic activity of ulcerative colitis. J Gastroenterol, 1999, 34:66-74.
  • 5Van den Brande JM, Braat H, van den Brink GR, et al. Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn' s disease. Gastroenterology, 2003, 124:1774-1785.
  • 6Chey WY, Hussain A, Ryan C, Potter GD. Infliximab for refractory ulcerative colitis. Am J Gastroenterol, 2001, 96: 2373-2381.
  • 7Rutgeerts P, Van Assche G, Vermeire S. Optimizing anti-TNF treatment in Inflammatory bowel disease. Gastroenterol, 2004, 126 : 1593-1610.
  • 8Summers RW. Novel and future medical management of Inflammatory bowel disease. Surg Clin North Am, 2007, 87: 727-741.
  • 9American gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21-23, 2006. Gastroenterology, 2007, 133 : 312-339.
  • 10Watkins PE, Warren BF, Stephens S, et al. Treatment of ulcerative colitis in the cottontop tamarin using antibody to tumour necrosis factor alpha. Gut, 1997,40:628-633.

同被引文献23

引证文献2

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部